Literature DB >> 26539251

Effect of Local Anesthetics on Human Mesenchymal Stromal Cell Secretion.

Andrea Gray1, Ileana Marrero-Berrios1, Mehdi Ghodbane1, Timothy Maguire1, Jonathan Weinberg2, Devasena Manchikalapati2, Joseph SchianodiCola2, Rene S Schloss1, Joel Yarmush2.   

Abstract

Anti-fibrotic and tissue regenerative mesenchymal stromal cell (MSC) properties are largely mediated by secreted cytokines and growth factors. MSCs are implanted to augment joint cartilage replacement and to treat diabetic ulcers and burn injuries simultaneously with local anesthetics, which reduce pain. However, the effect of anesthetics on therapeutic human MSC secretory function has not been evaluated. In order to assess the effect of local anesthetics on the MSC secretome, a panel of four anesthetics with different potencies - lidocaine, procaine, ropivacaine and bupivacaine - was evaluated. Since injured tissues secrete inflammatory cytokines, the effects of anesthetics on MSCs stimulated with tumor necrosis factor (TNF)-α and interferon (IFN)-γ were also measured. Dose dependent and anesthesia specific effects on cell viability, post exposure proliferation and secretory function were quantified using alamar blue reduction and immunoassays, respectively. Computational pathway analysis was performed to identify upstream regulators and molecular pathways likely associated with the effects of these chemicals on the MSC secretome. Our results indicated while neither lidocaine nor procaine greatly reduced unstimulated cell viability, ropivacaine and bupivacaine induced dose dependent viability decreases. This pattern was exaggerated in the simulated inflammatory environment. The reversibility of these effects after withdrawal of the anesthetics was attenuated for TNF-α/IFN-γ-stimulated MSCs exposed to ropivacaine and bupivacaine. In addition, secretome analysis indicated that constitutive secretion changes were clearly affected by both anesthetic alone and anesthetic plus TNFα/IFNγ cell stimulation, but the secretory pattern was drug specific and did not necessarily coincide with viability changes. Pathway analysis identified different intracellular regulators for stimulated and unstimulated MSCs. Within these groups, ropivacaine and bupivacaine appeared to act on MSCs similarly via the same regulatory mechanisms. Given the variable effect of local anesthetics on MSC viability and function, these studies underscore the need to evaluate MSC in the presence of medications, such as anesthetics, that are likely to accompany cell implantation.

Entities:  

Keywords:  Mesenchymal stromal cells; local anesthetics; pathway analysis; secretome

Year:  2015        PMID: 26539251      PMCID: PMC4630030          DOI: 10.1142/S1793984415500014

Source DB:  PubMed          Journal:  Nano Life        ISSN: 1793-9844


  43 in total

1.  Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis.

Authors:  Uta Kunter; Song Rong; Zivka Djuric; Peter Boor; Gerhard Müller-Newen; Donghai Yu; Jürgen Floege
Journal:  J Am Soc Nephrol       Date:  2006-06-21       Impact factor: 10.121

Review 2.  Anti-inflammatory properties of local anesthetics and their present and potential clinical implications.

Authors:  J Cassuto; R Sinclair; M Bonderovic
Journal:  Acta Anaesthesiol Scand       Date:  2006-03       Impact factor: 2.105

Review 3.  Mechanisms of mesenchymal stromal cell immunomodulation.

Authors:  Karen English
Journal:  Immunol Cell Biol       Date:  2012-10-23       Impact factor: 5.126

Review 4.  MAP kinase pathways activated by stress: the p38 MAPK pathway.

Authors:  T Obata; G E Brown; M B Yaffe
Journal:  Crit Care Med       Date:  2000-04       Impact factor: 7.598

5.  Adipose-derived mesenchymal stem cells exert antiinflammatory effects on chondrocytes and synoviocytes from osteoarthritis patients through prostaglandin E2.

Authors:  Cristina Manferdini; Marie Maumus; Elena Gabusi; Anna Piacentini; Giuseppe Filardo; Julie-Anne Peyrafitte; Christian Jorgensen; Philippe Bourin; Sandrine Fleury-Cappellesso; Andrea Facchini; Danièle Noël; Gina Lisignoli
Journal:  Arthritis Rheum       Date:  2013-05

6.  In vitro, inhibition of mitogen-activated protein kinase pathways protects against bupivacaine- and ropivacaine-induced neurotoxicity.

Authors:  Philipp Lirk; Ingrid Haller; Hans Peter Colvin; Leopold Lang; Bettina Tomaselli; Lars Klimaschewski; Peter Gerner
Journal:  Anesth Analg       Date:  2008-05       Impact factor: 5.108

7.  A comparative evaluation of local application of the combination of eutectic mixture of local anesthetics and capsaicin for attenuation of venipuncture pain.

Authors:  Devendra Gupta; Kamal Kishore; Sonal Rastogi; Prabhat K Singh; Anil Agarwal; Uttam Singh
Journal:  Anesth Analg       Date:  2013-02-11       Impact factor: 5.108

8.  Prolonged duration local anesthesia with minimal toxicity.

Authors:  Hila Epstein-Barash; Iris Shichor; Albert H Kwon; Sherwood Hall; Michael W Lawlor; Robert Langer; Daniel S Kohane
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-13       Impact factor: 11.205

Review 9.  Utilization of neural stem cell-derived models to study anesthesia-related toxicity and preventative approaches.

Authors:  Cheng Wang; Fang Liu; Tucker A Patterson; Merle G Paule; William Slikker
Journal:  Mol Neurobiol       Date:  2013-07-12       Impact factor: 5.590

10.  Mesenchymal stem cell therapy modulates the inflammatory response in experimental traumatic brain injury.

Authors:  Layla T Galindo; Thais R M Filippo; Patricia Semedo; Carolina B Ariza; Caroline M Moreira; Niels O S Camara; Marimelia A Porcionatto
Journal:  Neurol Res Int       Date:  2011-06-09
View more
  5 in total

1.  The effect of local anesthetic on pro-inflammatory macrophage modulation by mesenchymal stromal cells.

Authors:  Andrea Gray; Ileana Marrero-Berrios; Jonathan Weinberg; Devasena Manchikalapati; Joseph SchianodiCola; Rene S Schloss; Joel Yarmush
Journal:  Int Immunopharmacol       Date:  2016-02-06       Impact factor: 4.932

Review 2.  Mesenchymal Stem/Progenitor Cells: The Prospect of Human Clinical Translation.

Authors:  Dina Rady; Marwa M S Abbass; Aiah A El-Rashidy; Sara El Moshy; Israa Ahmed Radwan; Christof E Dörfer; Karim M Fawzy El-Sayed
Journal:  Stem Cells Int       Date:  2020-08-11       Impact factor: 5.443

3.  Alginate encapsulation for bupivacaine delivery and mesenchymal stromal cell immunomodulatory cotherapy.

Authors:  Mollie S Davis; Ileana Marrero-Berrios; Isabel Perez; Charles P Rabolli; Palangat Radhakrishnan; Devasena Manchikalapati; Joseph Schianodicola; Hattiyangangadi Kamath; Rene S Schloss; Joel Yarmush
Journal:  J Inflamm Res       Date:  2019-03-12

4.  A controlled release bupivacaine-alginate construct: Effect on chondrocyte hypertrophy conversion.

Authors:  Mollie S Davis; Ileana Marrero-Berrios; Xiomara I Perez; Palangat Radhakrishnan; Devasena Manchikalapati; Khaja Ahmed; Hattiyangangadi Kamath; Rene S Schloss; Joel Yarmush
Journal:  Osteoarthr Cartil Open       Date:  2020-11-19

5.  Alginate-liposomal construct for bupivacaine delivery and MSC function regulation.

Authors:  Mollie S Davis; Ileana Marrero-Berrios; Isabel Perez; Timothy Maguire; Palangat Radhakrishnan; Devasena Manchikalapati; Joseph SchianodiCola; Hattiyangangadi Kamath; Rene S Schloss; Joel Yarmush
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.